1Day Sooner

1Day Sooner

250px
Formation	2020
Type	Non-profit organization
Purpose	Advocacy for human challenge trials
Headquarters	New York City, United States
Website	1daysooner.org

1Day Sooner is a non-profit organization that advocates for the use of human challenge trials in the development of vaccines and treatments for infectious diseases, including COVID-19. The organization was founded in 2020 in response to the global pandemic, with the aim of accelerating the development of vaccines by supporting and organizing volunteers willing to participate in such trials.

Background

Human challenge trials involve intentionally exposing participants to a pathogen in a controlled setting to study the effects of the disease and the efficacy of potential vaccines or treatments. These trials can potentially speed up the process of vaccine development by providing quicker results compared to traditional clinical trials.

History

1Day Sooner was established in early 2020 by a group of volunteers and researchers who saw the potential benefits of human challenge trials in the fight against COVID-19. The organization quickly gained attention by gathering over 30,000 volunteers from around the world who expressed willingness to participate in such trials.

Mission and Activities

The mission of 1Day Sooner is to advocate for the safe and ethical use of human challenge trials to accelerate the development of vaccines and treatments for infectious diseases. The organization works to:

• Raise awareness about the potential benefits and ethical considerations of human challenge trials.
• Support scientific research and policy development related to human challenge trials.
• Connect volunteers with researchers and institutions conducting challenge trials.

1Day Sooner collaborates with scientists, ethicists, and policymakers to ensure that human challenge trials are conducted safely and ethically. The organization also engages in public outreach and education to inform the public about the role of these trials in medical research.

Ethical Considerations

The use of human challenge trials raises significant ethical questions, particularly regarding the safety and informed consent of participants. 1Day Sooner emphasizes the importance of rigorous ethical standards and informed consent processes to protect participants. The organization advocates for transparency and accountability in the design and conduct of these trials.

Impact

1Day Sooner has played a significant role in the global conversation about the use of human challenge trials during the COVID-19 pandemic. The organization's efforts have contributed to increased awareness and consideration of these trials as a tool for accelerating vaccine development.

Criticism

While 1Day Sooner has garnered support from many in the scientific community, it has also faced criticism from those who question the ethics and safety of human challenge trials. Critics argue that exposing healthy volunteers to a potentially deadly virus poses significant risks and that the benefits may not outweigh these risks.

Also see

• Human challenge study
• Vaccine development
• Clinical trial
• Informed consent
• Ethics in medical research